259 related articles for article (PubMed ID: 22119245)
1. Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.
Diaz JA; Ballard-Lipka NE; Farris DM; Hawley AE; Wrobleski SK; Myers DD; Henke PK; Lawrence DA; Wakefield TW
J Vasc Surg; 2012 Mar; 55(3):815-22. PubMed ID: 22119245
[TBL] [Abstract][Full Text] [Related]
2. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
[TBL] [Abstract][Full Text] [Related]
3. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
Sood V; Luke CE; Deatrick KB; Baldwin J; Miller EM; Elfline M; Upchurch GR; Wakefield TW; Henke PK
Thromb Haemost; 2010 Dec; 104(6):1174-83. PubMed ID: 20886179
[TBL] [Abstract][Full Text] [Related]
4. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
[TBL] [Abstract][Full Text] [Related]
5. Vein wall remodeling after deep vein thrombosis: differential effects of low molecular weight heparin and doxycycline.
Sood V; Luke C; Miller E; Mitsuya M; Upchurch GR; Wakefield TW; Myers DD; Henke PK
Ann Vasc Surg; 2010 Feb; 24(2):233-41. PubMed ID: 20142002
[TBL] [Abstract][Full Text] [Related]
6. Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.
Siefert SA; Chabasse C; Mukhopadhyay S; Hoofnagle MH; Strickland DK; Sarkar R; Antalis TM
J Thromb Haemost; 2014 Oct; 12(10):1706-16. PubMed ID: 25041188
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the TNF-α (Tumor Necrosis Factor-α)-TNF-Rp55 (Tumor Necrosis Factor Receptor p55) Axis in the Resolution of Venous Thrombus.
Nosaka M; Ishida Y; Kimura A; Kuninaka Y; Taruya A; Furuta M; Mukaida N; Kondo T
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2638-2650. PubMed ID: 30354252
[TBL] [Abstract][Full Text] [Related]
8. Plasmin inhibition increases MMP-9 activity and decreases vein wall stiffness during venous thrombosis resolution.
Dewyer NA; Sood V; Lynch EM; Luke CE; Upchurch GR; Wakefield TW; Kunkel S; Henke PK
J Surg Res; 2007 Oct; 142(2):357-63. PubMed ID: 17574586
[TBL] [Abstract][Full Text] [Related]
9. Deep vein thrombosis resolution is impaired in diet-induced type 2 diabetic mice.
Bouzeghrane F; Zhang X; Gevry G; Raymond J
J Vasc Surg; 2008 Dec; 48(6):1575-84. PubMed ID: 18829216
[TBL] [Abstract][Full Text] [Related]
10. Thrombogenesis with continuous blood flow in the inferior vena cava. A novel mouse model.
Diaz JA; Hawley AE; Alvarado CM; Berguer AM; Baker NK; Wrobleski SK; Wakefield TW; Lucchesi BR; Myers DD
Thromb Haemost; 2010 Aug; 104(2):366-75. PubMed ID: 20589322
[TBL] [Abstract][Full Text] [Related]
11. Venous stasis-induced fibrinolysis prevents thrombosis in mice: role of α2-antiplasmin.
Singh S; Houng AK; Reed GL
Blood; 2019 Sep; 134(12):970-978. PubMed ID: 31395599
[TBL] [Abstract][Full Text] [Related]
12. The effect of matrix metalloproteinase 2 and matrix metalloproteinase 2/9 deletion in experimental post-thrombotic vein wall remodeling.
Deatrick KB; Luke CE; Elfline MA; Sood V; Baldwin J; Upchurch GR; Jaffer FA; Wakefield TW; Henke PK
J Vasc Surg; 2013 Nov; 58(5):1375-1384.e2. PubMed ID: 23490298
[TBL] [Abstract][Full Text] [Related]
13. Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects.
Patterson KA; Zhang X; Wrobleski SK; Hawley AE; Lawrence DA; Wakefield TW; Myers DD; Diaz JA
Thromb Res; 2013 Mar; 131(3):268-76. PubMed ID: 23276528
[TBL] [Abstract][Full Text] [Related]
14. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator-1 overexpression decreases experimental postthrombotic vein wall fibrosis by a non-vitronectin-dependent mechanism.
Obi AT; Diaz JA; Ballard-Lipka NL; Roelofs KJ; Farris DM; Lawrence DA; Wakefield TW; Henke PK
J Thromb Haemost; 2014 Aug; 12(8):1353-63. PubMed ID: 24943740
[TBL] [Abstract][Full Text] [Related]
16. Simvastatin ameliorates deep vein thrombosis in rabbits by regulating the fibrinolytic system.
Feng Y; Zhang F; Niu L; Zhang M
Blood Coagul Fibrinolysis; 2016 Jul; 27(5):531-41. PubMed ID: 27273142
[TBL] [Abstract][Full Text] [Related]
17. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
[TBL] [Abstract][Full Text] [Related]
18. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
[TBL] [Abstract][Full Text] [Related]
19. Decreased venous thrombosis with an oral inhibitor of P selectin.
Myers DD; Rectenwald JE; Bedard PW; Kaila N; Shaw GD; Schaub RG; Farris DM; Hawley AE; Wrobleski SK; Henke PK; Wakefield TW
J Vasc Surg; 2005 Aug; 42(2):329-36. PubMed ID: 16102635
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of uPA, tPA, and PAI-1 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.
Nosaka M; Ishida Y; Kuninaka Y; Kimura A; Kondo T
Int J Legal Med; 2012 May; 126(3):421-5. PubMed ID: 22361951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
